These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22204342)

  • 1. Targeting SKCa channels in cancer: potential new therapeutic approaches.
    Girault A; Haelters JP; Potier-Cartereau M; Chantôme A; Jaffrés PA; Bougnoux P; Joulin V; Vandier C
    Curr Med Chem; 2012; 19(5):697-713. PubMed ID: 22204342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New alkyl-lipid blockers of SK3 channels reduce cancer cell migration and occurrence of metastasis.
    Girault A; Haelters JP; Potier-Cartereau M; Chantome A; Pinault M; Marionneau-Lambot S; Oullier T; Simon G; Couthon-Gourvès H; Jaffrès PA; Corbel B; Bougnoux P; Joulin V; Vandier C
    Curr Cancer Drug Targets; 2011 Nov; 11(9):1111-25. PubMed ID: 21999627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SK3/K(Ca)2.3 potassium channel is a new cellular target for edelfosine.
    Potier M; Chantome A; Joulin V; Girault A; Roger S; Besson P; Jourdan ML; LeGuennec JY; Bougnoux P; Vandier C
    Br J Pharmacol; 2011 Jan; 162(2):464-79. PubMed ID: 20955368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An amino acid outside the pore region influences apamin sensitivity in small conductance Ca2+-activated K+ channels.
    Nolting A; Ferraro T; D'hoedt D; Stocker M
    J Biol Chem; 2007 Feb; 282(6):3478-86. PubMed ID: 17142458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crucial role of a shared extracellular loop in apamin sensitivity and maintenance of pore shape of small-conductance calcium-activated potassium (SK) channels.
    Weatherall KL; Seutin V; Liégeois JF; Marrion NV
    Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18494-9. PubMed ID: 22025703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential formation of human heteromeric SK2:SK3 channels limits homomeric SK channel assembly and function.
    Butler AS; Hancox JC; Marrion NV
    J Biol Chem; 2023 Jan; 299(1):102783. PubMed ID: 36502918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the outer pore region of the apamin-sensitive Ca2+-activated K+ channel rSK2.
    Jäger H; Grissmer S
    Toxicon; 2004 Jun; 43(8):951-60. PubMed ID: 15208028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential assembly of heteromeric small conductance calcium-activated potassium channels.
    Church TW; Weatherall KL; Corrêa SA; Prole DL; Brown JT; Marrion NV
    Eur J Neurosci; 2015 Feb; 41(3):305-15. PubMed ID: 25421315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells.
    Steinestel K; Eder S; Ehinger K; Schneider J; Genze F; Winkler E; Wardelmann E; Schrader AJ; Steinestel J
    Tumour Biol; 2016 May; 37(5):6275-83. PubMed ID: 26619845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for involvement of both IKCa and SKCa channels in hyperpolarizing responses of the rat middle cerebral artery.
    McNeish AJ; Sandow SL; Neylon CB; Chen MX; Dora KA; Garland CJ
    Stroke; 2006 May; 37(5):1277-82. PubMed ID: 16556879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic hypoxia inhibits pregnancy-induced upregulation of SKCa channel expression and function in uterine arteries.
    Zhu R; Hu XQ; Xiao D; Yang S; Wilson SM; Longo LD; Zhang L
    Hypertension; 2013 Aug; 62(2):367-74. PubMed ID: 23716582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interactions of apamin and tetraethylammonium are differentially affected by single mutations in the pore mouth of small conductance calcium-activated potassium (SK) channels.
    Dilly S; Philippart F; Lamy C; Poncin S; Snyders D; Seutin V; Liégeois JF
    Biochem Pharmacol; 2013 Feb; 85(4):560-9. PubMed ID: 23270990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic coupling between TRPV4 and Ca
    Li Y; Hu H; Tian JB; Zhu MX; O'Neil RG
    Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1081-F1089. PubMed ID: 28274924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Disaccharide-Based Ether Lipids as SK3 Ion Channel Inhibitors.
    Berthe W; Sevrain CM; Chantôme A; Bouchet AM; Gueguinou M; Fourbon Y; Potier-Cartereau M; Haelters JP; Couthon-Gourvès H; Vandier C; Jaffrès PA
    ChemMedChem; 2016 Jul; 11(14):1531-9. PubMed ID: 27278812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correspondences between the binding characteristics of a non-natural peptide, Lei-Dab7, and the distribution of SK subunits in the rat central nervous system.
    Aidi-Knani S; Pezard L; Mpari B; Ben Hamida J; Sabatier JM; Mourre C; Regaya I
    Eur J Pharmacol; 2015 Apr; 752():106-11. PubMed ID: 25704615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a pharmacophore of SKCa channel blockers.
    Dilly S; Graulich A; Farce A; Seutin V; Liegeois JF; Chavatte P
    J Enzyme Inhib Med Chem; 2005 Dec; 20(6):517-23. PubMed ID: 16408787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two pathways for the activation of small-conductance potassium channels in neurons of substantia nigra pars reticulata.
    Yanovsky Y; Zhang W; Misgeld U
    Neuroscience; 2005; 136(4):1027-36. PubMed ID: 16203104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipidic synthetic alkaloids as SK3 channel modulators. Synthesis and biological evaluation of 2-substituted tetrahydropyridine derivatives with potential anti-metastatic activity.
    Kouba S; Braire J; Félix R; Chantôme A; Jaffrès PA; Lebreton J; Dubreuil D; Pipelier M; Zhang X; Trebak M; Vandier C; Mathé-Allainmat M; Potier-Cartereau M
    Eur J Med Chem; 2020 Jan; 186():111854. PubMed ID: 31753515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of SK3 channel as a new mediator of breast cancer cell migration.
    Potier M; Joulin V; Roger S; Besson P; Jourdan ML; Leguennec JY; Bougnoux P; Vandier C
    Mol Cancer Ther; 2006 Nov; 5(11):2946-53. PubMed ID: 17121942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting K
    Todesca LM; Maskri S; Brömmel K; Thale I; Wünsch B; Koch O; Schwab A
    Cell Physiol Biochem; 2021 May; 55(S3):131-144. PubMed ID: 34043300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.